This session addresses the growing field of medical isotope production and the implications for criticality safety. The field involves a number of emerging techniques and technologies which produce criticality safety challenges, INCLUDING handling high-assay low-enriched uranium in known or new chemical compositions. These challenges create opportunities for advancements in criticality safety techniques and demonstrate a continuing need for nuclear data. This panel is designed to highlight challenges, advancements, and current or future needs in the field of criticality safety for medical isotope production facilities.

Panelists

  • Jeff Chapman (National Nuclear Security Administration)
  • Joseph Christensen (SHINE Medical Technologies)
  • Katherin Goluoglu (Isotek Systems, LLC)
  • William Magwood IV (Director General, Nuclear Energy Agency)

Session Recording

To access the session recording, you must be logged in and registered for the meeting.

Register NowLog In

Discussion

There are 5 comments in this discussion.

To join the conversation, you must be logged in and registered for the meeting.

Register NowLog In